3-phenylpyrrolidine derivatives

Details 3-phenylpyrrolidine derivatives 3-phenylpyrrolidine derivatives

1995-03-06

1996-08-13

McKane, Joseph K.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514 85, 514 89, 514 91, 514 94, 514 95, 514 99, 514247, 514255, 514300, 514307, 514326, 514397, 514406, 514422, 514423, 514424, 514414, 548111, 548112, 548119, 5483641, 5483147, 548412, 548413, 548467, 548517, 548527, 548518, 548530, 548537, 548538, 548542, 546 21, 546 22, 546 23, 546337, 546122, 546146, 546208, 5462791, 544224, 544232, 544406, 546256, 5462784, A61K 31395, C07D20704

Patent

active

055456472

ABSTRACT:
3-Phenylpyrrolidine compounds of the formula ##STR1## effectively inhibit phosphodiesterase (PDE) IV activities and can be used as medicaments for conditions such as asthma.

REFERENCES:
CA87:39271K4-(Polyalkoxyphenyl)-2-pyrrolidinones. Huth et al., (1975).
CAS-Registry Handbook, 1977, Suppl. (StN Database) RN:63140-31-8.

Affiliated with

Also associated with

Rating

3-phenylpyrrolidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-phenylpyrrolidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-phenylpyrrolidine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1048113